Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Publication year range
1.
Ned Tijdschr Tandheelkd ; 126(9): 437-441, 2019 Sep.
Article in Dutch | MEDLINE | ID: mdl-31522209

ABSTRACT

In a general dental practice, attention was drawn to a patient by numerous deep carious cavities following bariatric surgery. In the research literature, indications can be found for a negative influence of bariatric surgery on oral health. Risk factors for caries, such as the number of cariogenic bacteria in saliva, inadequate quantity and quality of saliva, gastrooesophageal reflux and vomiting may be become more pronounced. Additionally, dietary habits will change due to the altered anatomy of the gastro-intestinal tract. Negative effects of bariatric surgery on periodontal tissue have also been found. However, it is conceivable that patients who are overweight already have poorer oral health prior to bariatric surgery,due to lifestyle and dietary habits, than comparable people who are not overweight. Health education programmes prior to and following bariatric surgery seem to have a positive effect on oral health. Initiating more research into oral health related to bariatric surgery is recommended.


Subject(s)
Bariatric Surgery , Dental Caries , Health Promotion/organization & administration , Bariatric Surgery/adverse effects , Dental Caries/epidemiology , Humans , Oral Health
2.
Neth J Med ; 75(2): 81-83, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28276328

ABSTRACT

Metamizole can be used in both short- and long-term pain relief therapies and has a relatively favourable safety profile compared with classic NSAIDs. Metamizole is also infamous because of its potential fatal adverse drug reaction, agranulocytosis. Although this risk varies, it is estimated to occur in less than one million metamizole prescriptions. We describe a case of a 68-year-old patient who developed leukopenia after using metamizole.


Subject(s)
Agranulocytosis/chemically induced , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Dipyrone/adverse effects , Aged , Humans , Male , Time Factors
3.
Surg Obes Relat Dis ; 11(5): 1099-104, 2015.
Article in English | MEDLINE | ID: mdl-25979208

ABSTRACT

BACKGROUND: The endoscopic ally implanted DJBL is a 60-cm impermeable fluoropolymer device, which prevents food from making contact with the proximal intestine. It was designed to induce weight loss and treat type 2 diabetes mellitus (T2DM). OBJECTIVES: To evaluate the feasibility, safety, and effectiveness of duodenal-jejunal bypass liner (DJBL) reimplantation. SETTING: Prospective, observational study was conducted at the department of surgery and gastroenterology of the Rijnstate hospital, Arnhem, the Netherlands, between 2009 and 2011. METHODS: Five obese patients with T2DM with body mass index (BMI) = Mass (kg) / height (m(2)), ranging from 30-35 kg/m(2) who completed the follow-up after their first implant and underwent removal of the DJBL after 6 months, were selected for reimplantation after an additional 18 months of follow-up. Weight loss, BMI, and HbA1 c were analyzed before and twelve months after reimplantation. RESULTS: In all 5 patients, the DJBL was implanted and explanted without any complications. Also the reimplantation and reexplantation occurred without any complications. Median weight decreased significantly from 105 kg to 95 kg, and BMI decreased from 33 to 29. The glycated hemoglobin (HbA1 c) level decreased from 8.4% to 7.3% by the first implantation but it wasn't significant. CONCLUSIONS: Reimplantation of DJBL is feasible, deemed safe, and showed additional weight loss.


Subject(s)
Diabetes Mellitus, Type 2/surgery , Duodenum/surgery , Jejunum/surgery , Obesity, Morbid/surgery , Replantation/methods , Bariatric Surgery/instrumentation , Bariatric Surgery/methods , Body Mass Index , Cohort Studies , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diagnosis , Endoscopy/methods , Feasibility Studies , Female , Follow-Up Studies , Humans , Male , Netherlands , Obesity, Morbid/complications , Obesity, Morbid/diagnosis , Prospective Studies , Replantation/instrumentation , Risk Assessment , Time Factors , Treatment Outcome
4.
Surg Obes Relat Dis ; 10(4): 633-40, 2014.
Article in English | MEDLINE | ID: mdl-25066440

ABSTRACT

BACKGROUND: For over a decade, the laparoscopic adjustable gastric band (LAGB) was 1 of the most performed bariatric procedures in Europe. This study is a retrospective analysis with prospectively collected data of the experience in 1 specialized Dutch center with the adjustable gastric band over 14 years. METHODS: Between 1995 and 2003, 201 patients underwent an LAGB for morbid obesity in our hospital. Data on preoperative clinical characteristic, postoperative outcome and weight loss patterns, and co-morbidities for up to 18 years are presented and evaluated using the Bariatric Analysis and Reporting Outcome System (BAROS). RESULTS: Average follow-up was 13.6 (± 2.0) years (163 mo) and 99% of patients with complete follow-up. Two thirds of patients reached an excess weight loss (EWL)>50% at some point after LAGB placement. However, due to insufficient weight loss or complications in 53% of patients, the LAGB had to be removed or converted to a Roux-en-Y gastric bypass. Additionally, half of the remaining patients had disappointing results according to the BAROS score. In total, less than one quarter (22%) of patients had a functioning band with a good result after the follow-up period. Although initially the number of patients experiencing co-morbidities was reduced, most of them returned and a large number of patients developed new co-morbidities. Complications, other than weight regain, were numerous as 47% of patients experienced at least 1. In total, 204 reoperations were performed in 137 (68%) patients. Furthermore, patients who were lost to follow-up did almost twice as bad in terms of EWL compared to patients who had regular follow-up. CONCLUSION: Morbid obesity is a chronic disease that can be resolved with bariatric surgery. One of the treatment options is the LAGB, which in the short term shows good results in terms of EWL and co-morbidity reduction. In the long term, however, EWL and co-morbidity reduction are disappointing, and the LAGB does not seem to live up to expectations. Besides the decrease in EWL over time, the number of reoperations required is alarming. In total, less than a quarter of patients still had a functioning band after a mean 14 years of follow-up.


Subject(s)
Gastric Bypass , Gastroplasty/adverse effects , Laparoscopy , Obesity, Morbid/surgery , Adult , Device Removal , Female , Follow-Up Studies , Gastroplasty/instrumentation , Humans , Male , Middle Aged , Obesity, Morbid/complications , Reoperation , Retrospective Studies , Time Factors , Treatment Outcome , Weight Loss , Young Adult
5.
Hum Mov Sci ; 32(1): 79-90, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23176813

ABSTRACT

The present study examined upper and lower limb coordination during lower limb asymmetry in a split-belt walking paradigm. Eleven healthy individuals walked on a split-belt treadmill with 4 different speed ratios (2:2, 2:4, 2:6 and 2:8 km/h) and the left belt fixed at 2 km/h. Spatial (upper and lower limb movement amplitudes) and temporal (correlations between trajectories) aspects of limb movement were analyzed. Results showed that while amplitudes of the right lower limb increased and left lower limb decreased with increasing asymmetry, both upper limb amplitudes increased. Correlations between diagonal upper/lower limb trajectories increased as right belt speed became faster, suggesting increasing cross-body matching regardless of side. As the treadmill asymmetry increased, ipsilateral lower/upper limbs became more out of phase suggesting a more precise gait pattern to regulate timing between limbs. The upper limbs reached maximum horizontal displacement before the lower limbs except between the right upper limb/left lower limb for asymmetrical belt speeds. From these results, it appears the faster moving lower limb drives the motion of both upper limbs. These changes are most likely due to neural mechanisms in which upper and lower limb CPGs regulate full body movement and maintain the rhythmic locomotor pattern.


Subject(s)
Arm/physiology , Gait/physiology , Leg/physiology , Orientation/physiology , Postural Balance/physiology , Psychomotor Performance/physiology , Walking/physiology , Acceleration , Adult , Biomechanical Phenomena/physiology , Female , Functional Laterality/physiology , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL